Protease inhibitors potentiate chemotherapy-induced neutropenia.
about
Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysisSurvival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapyBlood and marrow transplant for lymphoma patients with HIV/AIDS.Management of HIV infection in patients with cancer receiving chemotherapy.AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral TherapyRituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.Lung cancer in HIV infected patients: facts, questions and challenges.Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.Raltegravir use in special populationsThe pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.Emerging drugs in chronic myelogenous leukaemia.A systematic review on drug interactions in oncology.Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.Immunotherapy for HIV-associated non-Hodgkin's lymphoma.HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.Childhood cancer in Africa.Current status of treatment for primary effusion lymphoma.Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome.HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.The role of polymorphonuclear neutrophils during HIV-1 infection.A review of drug-drug interactions in older HIV-infected patients.Immune reconstitution inflammatory syndrome in AIDS-related non-hodgkin's lymphoma.Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicinRaltegravir-based HAART regimen in a patient with large B-cell lymphoma.Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease.Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients.HIV-related lymphomaBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q28391631-3B74798F-C5A0-4504-88E4-F764CFDFFE28Q33952616-F90B6430-F5F5-40D3-8F0D-0C16684D6E8CQ34068528-28EB32A3-FC20-4089-819A-4B2034443606Q35008342-AB0F7DF9-7BD8-45E6-A757-88D9B9AF9886Q35779619-AFE89223-06B4-40E1-8A4B-35D60137D6BAQ35848116-2C5CC835-F856-49F2-ABE3-6F0415FC1315Q36237964-8F413B36-5719-4EFB-BABE-3F223DDEF1E8Q36407441-762DE405-8FBC-4D1A-A12C-8406BD141C49Q36452179-97CF06AF-EF1E-4C7C-8E67-61D9514A8CACQ36620507-478EB40C-39AE-4162-94D0-A3F6C67FD1BEQ36634266-C64E88EF-2897-403B-8A5A-BDA301D4B495Q36659821-E9CE2F4A-16EC-46CC-A759-F08A87A17A35Q36693871-9EE9B51B-3964-4ADF-8912-E9B73F57EEC0Q37567836-DFE8F9F8-25A8-4BCD-9A4B-BEE8C570B2C8Q37658727-1279AA11-F469-4A37-BC75-5BA063331B55Q38161444-38ED197F-3508-422E-8951-0F35C941681AQ38264454-4A23F425-24A9-403B-B3BF-129CE7A0DB27Q38283075-458FD910-A65E-4868-B9C9-E159EE5A2AD9Q40512007-A379AB99-E6F5-49ED-8252-AF7C745EA18FQ41923884-6F1A6055-16E3-4D3E-91A1-B7CB0F6D3815Q41996857-F921C3B3-0FF8-46CA-BC82-34984C771C46Q42445411-01430504-01FE-4ACA-BBE3-C3D67CED0F48Q42610147-961778EE-BE78-4B4D-8977-E5166880CF74Q43205348-1C5CFE89-E479-486D-8517-A49F6ABCDE40Q45172725-4840DCBE-9AEA-46AA-B4E9-2E204C5CB9B4Q45202851-FCB6B8C6-1585-4F94-A7B6-3EEEFAB2194EQ45280472-562B5E9A-4A2D-4078-B2BC-A73204F17D92Q56112360-97DE0386-47B9-4EDD-9109-10A5B74F61CCQ57180790-57755C38-2F31-4B0D-8CB3-C79A6E7B207C
P2860
Protease inhibitors potentiate chemotherapy-induced neutropenia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@en
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@nl
type
label
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@en
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@nl
prefLabel
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@en
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@nl
P2093
P1433
P1476
Protease inhibitors potentiate chemotherapy-induced neutropenia.
@en
P2093
Anne Marie Young
Brian Gazzard
Justin Stebbing
Liz Davies
Mark Nelson
Natalie Ryan
Neil McCall-Peat
Srirupa Gupta
P304
P356
10.1182/BLOOD-2004-05-1747
P407
P50
P577
2004-07-06T00:00:00Z